| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 7.94% | UBS | → $17 | Initiates Coverage On | → Neutral |
| 11/03/2023 | 14.29% | Piper Sandler | $18.5 → $18 | Maintains | Overweight |
| 08/30/2023 | 11.11% | Compass Point | → $17.5 | Upgrades | Neutral → Buy |
| 08/11/2023 | 14.29% | JMP Securities | $15 → $18 | Maintains | Outperform |
| 08/04/2023 | 7.94% | Keefe, Bruyette & Woods | $13.5 → $17 | Upgrades | Underperform → Market Perform |
| 08/04/2023 | -4.76% | Oppenheimer | $13 → $15 | Maintains | Perform |
| 05/08/2023 | -4.76% | JMP Securities | $18 → $15 | Maintains | Market Outperform |
| 05/05/2023 | -26.98% | Keefe, Bruyette & Woods | $10.5 → $11.5 | Maintains | Underperform |
| 05/05/2023 | -17.46% | Wells Fargo | $13.5 → $13 | Maintains | Overweight |
| 04/06/2023 | 1.59% | Piper Sandler | → $16 | Upgrades | Neutral → Overweight |
| 03/13/2023 | 14.29% | JMP Securities | → $18 | Reiterates | → Market Outperform |
| 03/13/2023 | -33.33% | Keefe, Bruyette & Woods | $14.5 → $10.5 | Downgrades | Market Perform → Underperform |
| 02/21/2023 | 14.29% | JMP Securities | $17 → $18 | Maintains | Market Outperform |
| 02/17/2023 | 7.94% | RBC Capital | $16 → $17 | Maintains | Outperform |
| 02/17/2023 | -7.94% | Keefe, Bruyette & Woods | $12.5 → $14.5 | Maintains | Market Perform |
| 11/03/2022 | 1.59% | RBC Capital | $17 → $16 | Maintains | Outperform |
| 10/24/2022 | -7.94% | Wells Fargo | $15.5 → $14.5 | Maintains | Overweight |
| 10/03/2022 | -17.46% | Piper Sandler | $16 → $13 | Maintains | Neutral |
| 08/01/2022 | 14.29% | JMP Securities | $19 → $18 | Maintains | Market Outperform |
| 07/29/2022 | -4.76% | Oppenheimer | $18 → $15 | Downgrades | Outperform → Perform |
| 06/28/2022 | -1.59% | Piper Sandler | $18.5 → $15.5 | Maintains | Neutral |
| 04/25/2022 | 20.63% | Wells Fargo | $18.5 → $19 | Maintains | Overweight |
| 04/22/2022 | 14.29% | Keefe, Bruyette & Woods | → $18 | Downgrades | Outperform → Market Perform |
| 04/04/2022 | 20.63% | Piper Sandler | → $19 | Downgrades | Overweight → Neutral |
| 02/08/2022 | 14.29% | Compass Point | → $18 | Downgrades | Buy → Neutral |
| 04/28/2021 | 11.11% | Oppenheimer | → $17.5 | Initiates Coverage On | → Outperform |
| 03/25/2021 | 7.94% | RBC Capital | → $17 | Initiates Coverage On | → Outperform |
| 10/09/2020 | -17.46% | Piper Sandler | $12 → $13 | Maintains | Overweight |
| 09/09/2020 | -17.46% | JMP Securities | $12.5 → $13 | Maintains | Market Outperform |
| 07/31/2020 | -19.05% | Compass Point | $10.25 → $12.75 | Upgrades | Neutral → Buy |
| 06/19/2020 | -19.05% | Janney Montgomery Scott | → $12.75 | Upgrades | Neutral → Buy |
| 05/13/2020 | -14.29% | Wedbush | $15 → $13.5 | Maintains | Outperform |
| 05/05/2020 | -20.63% | JMP Securities | $16.5 → $12.5 | Maintains | Market Outperform |
| 05/05/2020 | -23.81% | B. Riley Securities | $11 → $12 | Maintains | Buy |
| 04/27/2020 | -28.57% | Wells Fargo | $10.75 → $11.25 | Maintains | Overweight |
| 04/06/2020 | -36.51% | Piper Sandler | $16 → $10 | Maintains | Overweight |
| 03/25/2020 | -31.75% | Wells Fargo | $16.5 → $10.75 | Maintains | Overweight |
| 03/24/2020 | -30.16% | B. Riley Securities | $17 → $11 | Maintains | Buy |
| 02/26/2020 | 4.76% | JMP Securities | $15 → $16.5 | Maintains | Market Outperform |
| 02/21/2020 | 7.94% | B. Riley Securities | $15 → $17 | Maintains | Buy |
| 11/04/2019 | — | Wells Fargo | Upgrades | Market Perform → Outperform | |
| 05/06/2019 | — | Wells Fargo | Downgrades | Outperform → Market Perform | |
| 05/03/2019 | -4.76% | B. Riley Securities | $11.5 → $15 | Upgrades | Neutral → Buy |
| 03/13/2019 | -26.98% | B. Riley Securities | $15 → $11.5 | Downgrades | Buy → Neutral |
| 03/13/2019 | — | Keefe, Bruyette & Woods | Downgrades | Outperform → Market Perform | |
| 03/13/2019 | — | Compass Point | Downgrades | Buy → Neutral |
What is the target price for Hercules Capital (HTGC)?
The latest price target for Hercules Capital (NYSE: HTGC) was reported by UBS on November 21, 2023. The analyst firm set a price target for $17.00 expecting HTGC to rise to within 12 months (a possible 7.94% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hercules Capital (HTGC)?
The latest analyst rating for Hercules Capital (NYSE: HTGC) was provided by UBS, and Hercules Capital initiated their neutral rating.
When is the next analyst rating going to be posted or updated for Hercules Capital (HTGC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hercules Capital, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hercules Capital was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Hercules Capital (HTGC) correct?
While ratings are subjective and will change, the latest Hercules Capital (HTGC) rating was a initiated with a price target of $0.00 to $17.00. The current price Hercules Capital (HTGC) is trading at is $15.75, which is within the analyst's predicted range.